BAD VILBEL (dpa-AFX) - Stada Arzneimittel AG (STDAY.PK, STDAF.PK) has been holding informal talks with private-equity firm CVC Capital Partners over a potential buyout that could value the Germany generic drugmaker at roughly 3.7 billion euros, the Wall Street Journal reported citing people familiar with the matter.
The talks come at a time when Stada finds itself under pressure from a German activist investor who is pushing for a wide-ranging overhaul, as well as other investors who are increasingly frustrated with management.
Stada's Chief Executive Hartmut Retzlaff held an initial meetings with CVC Capital Partners. Other private-equity firms have also reached out to Stada's management but it is unclear whether meetings have taken place yet.
If valued in line with recent transactions in the sector, Stada could be worth around 3.7 billion euros excluding debt, or up to roughly 60 euros per share, the report said.
Copyright RTT News/dpa-AFX